J. J. Finkelstein - President and CEO, Director at Regenerx Biopharmaceuticals Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
RGRX on OTC
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by J. J. Finkelstein since 12/23/2023

Holdings reported by J. J. Finkelstein for Regenerx Biopharmaceuticals Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.71M May 17, 2022 Direct
Stock Option (Right to Buy) 600K May 17, 2022 Direct Common Stock 500K
Convertible Promissory Note (right to buy) 20.9K May 17, 2022 Direct Common Stock 27.8K
Common Stock Warrant (right to buy) 0 May 17, 2022 Direct Common Stock 20.9K
Series A Common Stock Warrant (right to buy) 0 May 17, 2022 Direct Common Stock 56.3K
Series B Common Stock Warrant (right to buy) 0 May 17, 2022 Direct Common Stock 56.3K

Transactions reported by J. J. Finkelstein for Regenerx Biopharmaceuticals Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.